Preventive effect of hochu-ekki-to, a Japanese herbal medicine, on bleomycin-induced lung injury in mice

Respirology

Volumn 12, Issue 6, 2007, Pages 814-822

  Tajima, Shunji ^a,b   Bando, Masashi ^a   Yamasawa, Hideaki ^a   Ohno, Shoji ^a   Moriyama, Hiroshi ^b   Terada, Masaki ^b   Takada, Toshinori ^b   Suzuki, Eiichi ^b   Gejyo, Fumitake ^b   Sugiyama, Yukihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Bleomycin; Hochu ekki to; Kampo (traditional Japanese herbal) medicine; Pulmonary fibrosis; T helper type 2 cytokine

Indexed keywords

BLEOMYCIN; BU ZHONG YI QI TANG; GAMMA INTERFERON; HYDROXYPROLINE; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HISTOLOGY; LUNG; LUNG FIBROSIS; LUNG INJURY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; DRUGS, CHINESE HERBAL; FEMALE; HYDROXYPROLINE; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; TH1 CELLS; TH2 CELLS;

EID: 35748972619     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01146.x     Document Type: Article

References (27)

1. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 2001 345 : 517 25.
2. Duncan MR, Berman B. Gamma interferon is the lymphokine and interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J. Exp. Med. 1985 162 : 516 27.
3. Lawrence DA. Transforming growth factor-beta: a general review. Eur. Cytokine Netw. 1996 7 : 363 74.
4. Gharaee-Kermani M, Nozaki Y, Hatano K, Phan SH. Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine 2001 15 : 138 47.
5. Keane MP, Belperio JA, Burdick MD, Strieter RM. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2001 281 : L92 L7.
6. Tajima S, Bando M, Yamasawa H, Ohno S, Moriyama H et al. Preventive effect of hochu-ekki-to on lipopolysaccharide-induced acute lung injury in BALB/c mice. Lung 2006 184 : 318 23.
7. Gao XK, Fuseda K, Shibata T, Tanaka H, Inagaki N et al. Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice. Evid. Based Complement. Alternat. Med. 2005 2 : 191 9.
8. Kobayashi H, Mizuno N, Kutsuna H, Teramae H, Ueoku S et al. Hochu-ekki-to suppresses development of dermatitis and elevation of serum IgE level in NC/Nga mice. Drugs Exp. Clin. Res. 2003 29 : 81 4.
9. Kobayashi H, Mizuno N, Teramae H, Kutsuna H, Ueoku S et al. The effects of Hochu-ekki-to in patients with atopic dermatitis resistant to conventional treatment. Int. J. Tissue React. 2004 26 : 113 17.
10. Nakada T, Watanabe K, Matsumoto T, Santa K, Triizuka K et al. Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen. Int. Immunopharmacol. 2002 2 : 901 11.
11. Ishimitsu R, Nishimura H, Kawauchi H, Kawakita T, Yoshikai Y. Dichotomous effects of a traditional Japanese medicine, Bu-zhong-yi-qi-tang, on allergic asthma in mice. Int. Immunopharmacol. 2001 1 : 857 65.
12. Yamaoka Y, Kawakita T, Nomoto K. Protective effect of a traditional Japanese medicine, Hochu-ekki-to (Chinese name: Bu-zhong-yi-qi-tang), on the susceptibility against Listeria monocytogenes in infant mice. Int. Immunopharmacol. 2001 1 : 1669 77.
13. Ochi T, Kawakita T, Nomoto K. Effects of Hochu-ekki-to and Ninjin-youei-to, traditional Japanese medicines, on porcine serum-induced liver fibrosis in rats. Immunopharmacol. Immunotoxicol. 2004 26 : 285 98.
14. Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N et al. Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12. Am. J. Physiol. Lung Cell Mol. Physiol. 2001 280 : L1128 37.
15. Harrison JH, Lazo JS. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J. Pharmacol. Exp. Ther. 1987 243 : 1185 94.
16. Yanagisawa K, Naito Y, Kuroiwa K, Arai T, Furukawa Y et al. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. J. Biochem. (Tokyo) 1997 121 : 95 103.
17. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001 134 : 136 51.
18. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am. J. Respir. Crit. Care Med. 2006 173 : 769 76.
19. Nakada T, Watanabe K, Jin G, Santa K, Kato H et al. Effects of Kampo medicines on Th1/Th2 balance. Influence of the duration of administration. J. Tradit. Med. 1998 15 : 376 7.
20. Majumdar S, Li D, Ansari T, Pantelidis P, Black CM et al. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. Eur. Respir. J. 1999 14 : 251 7.
21. Gharaee-Kermani M, Phan SH. Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 1997 16 : 438 47.
22. Gharaee-Kermani M, McGarry B, Lukacs N, Huffnagle G, Egan RW et al. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 1998 64 : 657 66.
23. Tamura R, Takahashi HK, Xue D, Kubo S, Saito S et al. Enhanced effects of combined bu-zhong-yi-qi-tang (TJ-41) and interleukin-18 on the production of tumour necrosis factor-alpha and interferon-gamma in human peripheral blood mononuclear cells. J. Int. Med. Res. 2004 32 : 25 32.
24. Gong LK, Li XH, Wang H, Zhang L, Cai Y et al. Feitai attenuates bleomycin-induced pulmonary fibrosis in rats. Biol. Pharm. Bull. 2004 27 : 634 40.
25. Gong LK, Li XH, Wang H, Zhang L, Chen FP et al. Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats. J. Ethnopharmacol. 2005 96 : 537 44.
26. Shen Y, Du HL, Zhao J, Li YT, Tan F et al. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice. Clin. Exp. Pharmacol. Physiol. 2005 32 : 1071 7.
27. Dai LJ, Hou J, Cai HR. Experimental study on treatment of pulmonary fibrosis by Chinese drugs and integrative Chinese and Western medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004 24 : 130 2.